Startseite/Aktien/CELC

CELC

USD

Celcuity Inc. Common Stock

$12.570+0.250 (2.029%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$12.320

Hoch

$12.770

Tief

$12.320

Volumen

0.13M

Unternehmensfundamentaldaten

Marktkapitalisierung

476.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.23M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $7.575Aktuell $12.570Hoch $19.77

Ähnliche Nachrichten

19. Mai 2025 · 10:57

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity with a Buy and maintains $27 price target.

HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target

15. Mai 2025 · 10:39

Analyst Upgrades

Needham Reiterates Buy on Celcuity, Maintains $29 Price Target

Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $29 price target.

Needham Reiterates Buy on Celcuity, Maintains $29 Price Target

14. Mai 2025 · 20:01

GlobeNewswire

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

7. Mai 2025 · 11:05

GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call

MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its